Improved lentiviral transduction of ALS motoneurons in vivo via dual targeting

Molecular Pharmaceutics

Volumn 10, Issue 11, 2013, Pages 4195-4206

  O'Leary, Valerie B ^a,b   Ovsepian, Saak V ^a,c   Bodeker, Macdara ^a,d   Dolly, J Oliver ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d Atlantic Technological University   (Ireland)

Author keywords

ALS; CS TeTIM; lentivirus; pseudotyping; rabies glycoprotein; SOD1; tetanus toxin

Indexed keywords

ADAPTOR PROTEIN; ALANINE; CHOLINE ACETYLTRANSFERASE; GLYCINE; GLYCOPROTEIN; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; RABIES GLYCOPROTEIN; RNA; STREPTAVIDIN; TETANUS TOXIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

AMINO ACID SUBSTITUTION; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN STEM; CONTROLLED STUDY; DRUG TARGETING; GENE EXPRESSION; GENETIC ENGINEERING; GENETIC TRANSDUCTION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOTONEURON; MOUSE; NERVE CELL; NERVE FIBER; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOTYPING; REPORTER GENE; SITE DIRECTED MUTAGENESIS; SPINAL CORD; SYMPTOM; VESICULAR STOMATITIS VIRUS; VIRAL GENE DELIVERY SYSTEM; WILD TYPE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; FEMALE; GLYCOPROTEINS; GREEN FLUORESCENT PROTEINS; LENTIVIRUS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; SPINAL CORD; STREPTAVIDIN; TETANUS TOXIN;

EID: 84887327155     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400247t     Document Type: Article

References (80)

1. Logroscino, G. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues J. Neurol., Neurosurg. Psychiatry 2008, 79, 6-11
2. Siddique, T.; Deng, H. X. Genetics of amyotrophic lateral sclerosis. Hum. Mol. Genet. Spec No. 1996, 5, 1465-70.
3. Gould, T. W.; Oppenheim, R. W. Motor neuron trophic factors: therapeutic use in ALS? Brain Res. Rev. 2011, 67, 1-39
4. Valentine, J. S.; Doucette, P. A.; Zittin Potter, S. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis Annu. Rev. Biochem. 2005, 74, 563-93
5. Ferraiuolo, L.; Kirby, J.; Grierson, A. J.; Sendtner, M.; Shaw, P. J. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis Nat. Rev. Neurol. 2011, 7, 616-30
6. Gowing, G.; Svendsen, C. N. Stem cell transplantation for motor neuron disease: current approaches and future perspectives Neurotherapeutics 2011, 8, 591-606
7. Contestabile, A. Amyotrophic lateral sclerosis: from research to therapeutic attempts and therapeutic perspectives Curr. Med. Chem. 2011, 18, 5655-65
8. Gurney, M. E. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation Science 1994, 264, 1772-5
9. Calvo, A. C. Lack of a synergistic effect of a non-viral ALS gene therapy based on BDNF and a TTC fusion molecule Orphanet J. Rare Dis. 2011, 6, 10
10. Turner, B. J.; Talbot, K. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS Prog. Neurobiol. 2008, 85, 94-134
11. Williamson, T. L.; Cleveland, D. W. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons Nat. Neurosci. 1999, 2, 50-6
12. Zhang, B.; Tu, P.; Abtahian, F.; Trojanowski, J. Q.; Lee, V. M. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation J. Cell Biol. 1997, 139, 1307-15
13. Ciriza, J. A genetic fusion GDNF-C fragment of tetanus toxin prolongs survival in a symptomatic mouse ALS model Restor. Neurol. Neurosci. 2008, 26, 459-65
14. Li, Y. Recombinant forms of tetanus toxin engineered for examining and exploiting neuronal trafficking pathways J. Biol. Chem. 2001, 276, 31394-401
15. Fishman, P. S. Tetanus Toxin. In Botulinum Toxin: therapeutic clinical practice and science; Saunders Elsevier: 2009; pp 406-24.
16. O'Leary, V. B. Innocuous full-length botulinum neurotoxin targets and promotes the expression of lentiviral vectors in central and autonomic neurons Gene Ther. 2011, 18, 656-65
17. Edupuganti, O. P. Targeted delivery into motor nerve terminals of inhibitors for SNARE-cleaving proteases via liposomes coupled to an atoxic botulinum neurotoxin FEBS J. 2012, 279, 2555-67
18. Sano, T.; Vajda, S.; Cantor, C. R. Genetic engineering of streptavidin, a versatile affinity tag J. Chromatogr., B: Biomed. Sci. Appl. 1998, 715, 85-91
19. Kaspar, B. K.; Llado, J.; Sherkat, N.; Rothstein, J. D.; Gage, F. H. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model Science 2003, 301, 839-42
20. Ralph, G. S. Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model Nat. Med. 2005, 11, 429-33
21. Mazarakis, N. D. Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery Hum. Mol. Genet. 2001, 10, 2109-21
22. Azzouz, M. Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy J. Clin. Invest. 2004, 114, 1726-31
23. Mentis, G. Z. Transduction of motor neurons and muscle fibers by intramuscular injection of HIV-1-based vectors pseudotyped with select rabies virus glycoproteins J. Neurosci. Methods 2006, 157, 208-17
24. Pahler, A.; Hendrickson, W. A.; Kolks, M. A.; Argarana, C. E.; Cantor, C. R. Characterization and crystallization of core streptavidin J. Biol. Chem. 1987, 262, 13933-7
25. Hemsley, A.; Arnheim, N.; Toney, M. D.; Cortopassi, G.; Galas, D. J. A simple method for site-directed mutagenesis using the polymerase chain reaction Nucleic Acids Res. 1989, 17, 6545-51
26. Li, Y. A single mutation in the recombinant light chain of tetanus toxin abolishes its proteolytic activity and removes the toxicity seen after reconstitution with native heavy chain Biochemistry 1994, 33, 7014-20
27. Studier, F. W. Protein production by auto-induction in high density shaking cultures Protein Expression Purif. 2005, 41, 207-34
28. Sena-Esteves, M.; Tebbets, J. C.; Steffens, S.; Crombleholme, T.; Flake, A. W. Optimized large-scale production of high titer lentivirus vector pseudotypes J. Virol. Methods 2004, 122, 131-9
29. Boussif, O. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 7297-301
30. Moore, J. P.; McKeating, J. A.; Weiss, R. A.; Sattentau, Q. J. Dissociation of gp120 from HIV-1 virions induced by soluble CD4 Science 1990, 250, 1139-42
31. Green, N. M.; Toms, E. J. Purification and crystallization of avidin Biochem. J. 1970, 118, 67-70
32. Choi, C. I. Effects of estrogen on lifespan and motor functions in female hSOD1 G93A transgenic mice J. Neurol. Sci. 2008, 268, 40-7
33. Zangala, T. Isolation of genomic DNA from mouse tails J. Visualized Exp. 2007, 10.3791/246
34. Leitner, M.; Menzies, S.; Lutz, C. Working with ALS mice-Guidelines for preclinical testing and colony management; The Jackson Laboratory: Bar Harbor, ME, and Prize4Life, Inc.: Cambridge, MA, 2009.
35. Crawley, J. N. Behavioral phenotyping strategies for mutant mice Neuron 2008, 57, 809-18
36. Culling, C. F. A.; Allison, R. T.; Barr, W. T. Cellular Pathology Technique; Butterworths: London, 1985.
37. Daniel-Christoph, W. Object-based analysis of astroglial reaction and astrocyte subtype morphology after ischemic brain injury Acta Neurobiol. Exp. 2012, 73, 79-87
38. Sholl, A.; Uttley, A. M. Pattern discrimination and the visual cortex Nature 1953, 171, 387-8
39. Raghunath, A.; Perez-Branguli, F.; Smith, L.; Dolly, J. O. Adeno-associated virus transfer of a gene encoding SNAP-25 resistant to botulinum toxin A attenuates neuromuscular paralysis associated with botulism J. Neurosci. 2008, 28, 3683-8
40. Brewis, N. Evaluation of VP22 spread in tissue culture J. Virol. 2000, 74, 1051-6
41. Veldink, J. H. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS Neuromuscular Disord. 2003, 13, 737-43
42. Wooley, C. M. Gait analysis detects early changes in transgenic SOD1(G93A) mice Muscle Nerve 2005, 32, 43-50
43. Federici, T. Comparative analysis of HIV-1-based lentiviral vectors bearing lyssavirus glycoproteins for neuronal gene transfer Genet. Vaccines Ther. 2009, 7, 1
44. Garbuzova-Davis, S. Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS PLoS One 2007, 2, e1205
45. Bilsland, L. G. Deficits in axonal transport precede ALS symptoms in vivo Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 20523-8
46. Jakobsson, J.; Lundberg, C. Lentiviral vectors for use in the central nervous system Mol. Ther. 2006, 13, 484-93
47. Zufferey, R.; Nagy, D.; Mandel, R. J.; Naldini, L.; Trono, D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo Nat. Biotechnol. 1997, 15, 871-5
48. Dull, T. A third-generation lentivirus vector with a conditional packaging system J. Virol. 1998, 72, 8463-71
49. Naldini, L.; Blomer, U.; Gage, F. H.; Trono, D.; Verma, I. M. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 11382-8
50. Waehler, R.; Russell, S. J.; Curiel, D. T. Engineering targeted viral vectors for gene therapy Nat. Rev. Genet. 2007, 8, 573-87
51. Watson, D. J.; Kobinger, G. P.; Passini, M. A.; Wilson, J. M.; Wolfe, J. H. Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins Mol. Ther. 2002, 5, 528-37
52. Kordower, J. H. Lentiviral gene transfer to the nonhuman primate brain Exp. Neurol. 1999, 160, 1-16
53. Baekelandt, V. Characterization of lentiviral vector-mediated gene transfer in adult mouse brain Hum. Gene Ther. 2002, 13, 841-53
54. Jakobsson, J.; Ericson, C.; Jansson, M.; Bjork, E.; Lundberg, C. Targeted transgene expression in rat brain using lentiviral vectors J. Neurosci. Res. 2003, 73, 876-85
55. Jakobsson, J.; Rosenqvist, N.; Thompson, L.; Barraud, P.; Lundberg, C. Dynamics of transgene expression in a neural stem cell line transduced with lentiviral vectors incorporating the cHS4 insulator Exp. Cell Res. 2004, 298, 611-23
56. Georgievska, B. Regulated delivery of glial cell line-derived neurotrophic factor into rat striatum, using a tetracycline-dependent lentiviral vector Hum. Gene Ther. 2004, 15, 934-44
57. Williamson, T. L. Neurofilaments, radial growth of axons, and mechanisms of motor neuron disease Cold Spring Harbor Symp. Quant. Biol. 1996, 61, 709-23
58. Fishman, P. S.; Matthews, C. C.; Parks, D. A.; Box, M.; Fairweather, N. F. Immunization does not interfere with uptake and transport by motor neurons of the binding fragment of tetanus toxin J. Neurosci. Res. 2006, 83, 1540-3
59. Fezza, J. P.; Wiley, H. J.; Wesley, R.; Klippenstein, R. E.; Dettbarn, K. W. The effects of tetanus toxin on the orbicularis oculi muscle Ophthalmic Plast. Reconstr. Surg. 2002, 16, 101-113
60. Scott, A. B. Antitoxin reduces botulinum side effects Eye (London) 1988, 2 (Part 1) 29-32
61. Wiley, R. G.; Oeltmann, T. N. Anti-ricin antibody protects against systemic toxicity without affecting suicide transport J. Neurosci. Methods 1989, 27, 203-9
62. Gill, D. M. Bacterial toxins: a table of lethal amounts Microbiol. Rev. 1982, 46, 86-94
63. Schwab, M. E.; Suda, K.; Thoenen, H. Selective retrograde transsynaptic transfer of a protein, tetanus toxin, subsequent to its retrograde axonal transport J. Cell Biol. 1979, 82, 798-810
64. Francis, J. W.; Ren, J.; Warren, L.; Brown, R. H., Jr.; Finklestein, S. P. Postischemic infusion of Cu/Zn superoxide dismutase or SOD:Tet451 reduces cerebral infarction following focal ischemia/reperfusion in rats Exp. Neurol. 1997, 146, 435-43
65. Wang, J. Novel chimeras of botulinum and tetanus neurotoxins yield insights into their distinct sites of neuroparalysis FASEB J. 2012, 26, 5035-48
66. Cronin, J.; Zhang, X. Y.; Reiser, J. Altering the tropism of lentiviral vectors through pseudotyping Curr. Gene Ther. 2005, 5, 387-98
67. Tuffereau, C.; Benejean, J.; Blondel, D.; Kieffer, B.; Flamand, A. Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus EMBO J. 1998, 17, 7250-9
68. Herreros, J.; Ng, T.; Schiavo, G. Lipid rafts act as specialized domains for tetanus toxin binding and internalization into neurons Mol. Biol. Cell 2001, 12, 2947-60
69. Yeh, F. L. SV2 mediates entry of tetanus neurotoxin into central neurons PLoS Pathog. 2010, 6, e1001207
70. De Vos, K. J. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content Hum. Mol. Genet. 2007, 16, 2720-8
71. Ay, I.; Francis, J. W.; Brown, R. H., Jr. VEGF increases blood-brain barrier permeability to Evans blue dye and tetanus toxin fragment C but not adeno-associated virus in ALS mice Brain Res. 2008, 1234, 198-205
72. Bizzini, B.; Stoeckel, K.; Schwab, M. An antigenic polypeptide fragment isolated from tetanus toxin: chemical characterization, binding to gangliosides and retrograde axonal transport in various neuron systems J. Neurochem. 1977, 28, 529-42
73. Fishman, P. S.; Carrigan, D. R. Motoneuron uptake from the circulation of the binding fragment of tetanus toxin Arch. Neurol. 1988, 45, 558-61
74. Azzouz, M. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model Nature 2004, 429, 413-7
75. Haase, G. Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors Nat. Med. 1997, 3, 429-36
76. Keir, S. D.; Xiao, X.; Li, J.; Kennedy, P. G. Adeno-associated virus-mediated delivery of glial cell line-derived neurotrophic factor protects motor neuron-like cells from apoptosis J. Neurovirol. 2001, 7, 437-46
77. Acsadi, G. Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy Hum. Gene Ther. 2002, 13, 1047-59
78. Azzouz, M. Increased motoneuron survival and improved neuromuscular function in transgenic ALS mice after intraspinal injection of an adeno-associated virus encoding Bcl-2 Hum. Mol. Genet. 2000, 9, 803-11
79. Bordet, T. Protective effects of cardiotrophin-1 adenoviral gene transfer on neuromuscular degeneration in transgenic ALS mice Hum. Mol. Genet. 2001, 10, 1925-33
80. Alisky, J. M.; Davidson, B. L. Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases Hum. Gene Ther. 2000, 11, 2315-29